Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Celgene Corp (NASDAQ:CELG)

127.65
Delayed Data
As of Aug 18
 +0.07 / +0.05%
Today’s Change
96.93
Today|||52-Week Range
139.00
+10.28%
Year-to-Date

Today’s Trading

Previous close127.58
Today’s open127.43
Day’s range127.27 - 129.01
Volume4,270,548
Average volume (3 months)3,765,371
Market cap$99.9B
Dividend yield--
Data as of 4:00pm ET, 08/18/2017

Growth & Valuation

Earnings growth (last year)+28.35%
Earnings growth (this year)+23.17%
Earnings growth (next 5 years)+21.84%
Revenue growth (last year)+22.70%
P/E ratio39.6
Price/Sales8.51
Price/Book15.06

Competitors

 Today’s
change
Today’s
% change
GSKGlaxoSmithKline-0.30-0.77%
BMYBristol-Myers Squibb-0.35-0.62%
NVONovo Nordisk-0.16-0.35%
ABBVAbbVie+0.11+0.16%
Data as of 4:02pm ET, 08/18/2017

Financials

Next reporting dateOctober 26, 2017
EPS forecast (this quarter)$1.88
Annual revenue (last year)$10.9B
Annual profit (last year)$2.0B
Net profit margin18.30%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Mark J. Alles
President &
Chief Operating Officer
Scott Andrew Smith
Corporate headquarters
Summit, New Jersey

Forecasts